New data suggests Veracyte’s RNA-Seq based Afirma GSC can help patients avoid unnecessary thyroid surgery

March 20, 2018 Leave a comment 2,130 Views

Veracyte, Inc. today announced that new data presented at ENDO 2018, the annual meeting of the Endocrine Society, suggest that the Afirma Genomic Sequencing Classifier (GSC) can help significantly more

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Endocrine Society

New data suggests Veracyte’s RNA-Seq based Afirma GSC can help patients avoid unnecessary thyroid surgery

LACE-seq – global profiling of RNA-binding protein target sites

Researchers publish first transcriptomic study of decompression sickness

Microfluidic platform accelerates tissue processing into single cells for molecular analysis and primary culture models

Bias in RNA-seq Library Preparation

Identifying differentially expressed circular RNAs associated with DNA methylation change

Single-cell RNA sequencing reveals how kidney cancer develops and responds to treatment

ppcseq – probabilistic outlier identification for RNA sequencing generalized linear models